Sarkar P, Bergman K, O'Connor T G, Glover V
Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Campus, London, UK.
J Neuroendocrinol. 2008 Apr;20(4):489-96. doi: 10.1111/j.1365-2826.2008.01659.x. Epub 2008 Feb 8.
Both animal and human studies have shown that maternal stress or anxiety during pregnancy is associated with increased risk of disturbance in offspring neurodevelopment and behaviour. In animal models, increased foetal exposure to glucocorticoids has been found to be one mechanism for such foetal programming. Little is understood of the mediating mechanisms in humans, and one aim of our research programme is to investigate this further. This review presents a synopsis of some of our recent results. We aimed to test the hypothesis that maternal anxiety was associated with raised maternal cortisol, and that this in turn was related to increased foetal exposure to cortisol. We studied this by recruiting women at amniocentesis, obtained their Spielberger State Anxiety scores, and assessed maternal plasma cortisol and amniotic fluid cortisol. We also examined maternal plasma and amniotic fluid testosterone levels. Awaiting amniocentesis was in general anxiogenic, but with a wide range of anxiety scores. Maternal anxiety was significantly associated with plasma cortisol before 17 weeks, albeit of modest magnitude (r = 0.0.23), and not after 17 weeks of gestation. This is probably due to the known attenuation of the maternal hypothalamic-pituitary-adrenal axis with increasing gestation. We found a strong correlation between maternal plasma and amniotic fluid cortisol levels, which increased with gestation and became robust after 18 weeks. This correlation increased with maternal anxiety, suggesting a possible effect of maternal mood on placental function. There was a positive correlation between cortisol and testosterone in amniotic fluid, in both male and female foetuses independent of maternal anxiety, plasma testosterone, gestational age, and time of collection. Foetal stress may be associated with increased foetal exposure to testosterone. However, maternal anxiety did not predict amniotic fluid cortisol or testosterone level. Thus, the role of these hormones in mediating the effect of maternal mood on foetal development in humans remains to be demonstrated.
动物研究和人体研究均表明,孕期母亲的压力或焦虑与后代神经发育和行为障碍风险增加有关。在动物模型中,已发现胎儿暴露于糖皮质激素增加是这种胎儿编程的一种机制。对于人类的中介机制了解甚少,我们研究项目的一个目标是进一步对此进行调查。本综述概述了我们最近的一些研究结果。我们旨在检验以下假设:母亲焦虑与母亲皮质醇升高有关,而这反过来又与胎儿暴露于皮质醇增加有关。我们通过在羊膜穿刺术时招募女性、获取她们的斯皮尔伯格状态焦虑评分,并评估母亲血浆皮质醇和羊水皮质醇来研究这一问题。我们还检测了母亲血浆和羊水睾酮水平。等待羊膜穿刺术通常会引发焦虑,但焦虑评分范围很广。母亲焦虑与孕17周前的血浆皮质醇显著相关,尽管相关性较小(r = 0.23),而在妊娠17周后则无相关性。这可能是由于已知随着孕周增加母亲下丘脑 - 垂体 - 肾上腺轴会减弱。我们发现母亲血浆和羊水皮质醇水平之间存在很强的相关性,这种相关性随着孕周增加而升高,并在18周后变得显著。这种相关性随着母亲焦虑程度的增加而增强,表明母亲情绪可能对胎盘功能有影响。在羊水当中,无论胎儿性别,皮质醇与睾酮之间均存在正相关,且与母亲焦虑、血浆睾酮、孕周和采集时间无关。胎儿应激可能与胎儿暴露于睾酮增加有关。然而,母亲焦虑并不能预测羊水皮质醇或睾酮水平。因此,这些激素在介导母亲情绪对人类胎儿发育影响方面的作用仍有待证实。